Press Releases

Oncodesign, a drug discovery company and oncology pharmacology service provider, announces today that the company has entered into a strategic research collaboration with Sanofi to apply exclusively Oncodesign’s Nanocyclix(R) technology to several Sanofi kinase target programs.  ...

Torax Medical announced today that Eric Masingale has joined the company as Global Vice President of Sales and Marketing. Eric comes to Torax Medical after 18 years with Stryker Corp (NYSE: SYK), where he...

Dr. Reddy’s Laboratories announced today that is has launched Metoprolol Succinate ER (Extended-Release) Tablets (25 mg, 50 mg, 100 mg & 200 mg), a bioequivalent generic version of Toprol-XL® (Metoprolol Succinate) Tablets in the US market on September...

John Ware Research Group, Inc.,(JWRG), a leading health outcomes company, announces the launch of QOLIX, a patent pending Quality of Life Measurement Information System, a new, web-based patient-centered measurement application which improves patient outcomes measurement and makes them...

Pfizer Inc. announced that it has settled its litigation against Mylan Inc. and Mylan Pharmaceuticals Inc. relating to Pfizer’s patents covering Detrol LA® (tolterodine tartrate) extended-release capsules. As a result of this settlement, and...

OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer, today announced the online publication in Clinical Cancer Research of preclinical data demonstrating the potent anti-cancer activity of anti-DLL4 (demcizumab) in patient-derived pancreatic tumor models. ...

Simplify and improve your clinical laboratory with single-step, direct ELISA measurement of Free Testosterone from Gold Standard Diagnostics (GSD). Compared to indirect, multi-step testing algorithms, GSD’s FDA Cleared Free Testosterone products save laboratories time and...